Author: admin

Papers

2016

  • ReadBellone M, Di Virgilio R, Di Rienzo P. Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy. Farmeconomia. Health economics and therapeutic pathways 2016; 17(3): 127-136
  • ReadPradelli L, Ascierto P. Valutazione clinica ed economica dell’introduzione sul mercato italiano della combinazione trametinib + dabrafenib nel trattamento del melanoma in stadio avanzato. Farmeconomia. Health economics and therapeutic pathways 2016; 17(Suppl 3): 1-32
  • ReadDal Negro W, Povero M. Cultural and linguistic validation of the NHQ-2 Questionnaire: a specific instrument for assessing patient’s usability of inhalation devices. Multidiscip Respir Med. 2016 Aug 23;11:32
  • ReadDal Negro W, Povero M. Dry-powder inhalers in patients with persistent airflow limitation: usability and preference. Multidiscip Respir Med. 2016 Sep 5;11:31
  • ReadDal Negro W, Povero M. Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients. Multidiscip Respir Med. 2016 Feb 10;11:7
  • ReadAdami S, Maggi P, Montinaro V, Povero M, Pradelli L, Bellagamba R, Bonfanti P, Di Biagio A, Rusconi S, Di Campli FM, Forastieri G, Mancini M. Simulating the development and progression of Chronic Kidney Disease and osteoporosis in people living with HIV. Farmeconomia. Health economics and therapeutic pathways 2016;17(S1):3-23
  • ReadWu GH, Zaniolo O, Schuster H, Schlotzer E, Pradelli L. Structured triglycerides versus physical mixtures of medium- and long-chain triglycerides for parenteral nutrition in surgical or critically ill adult patients: Systematic review and meta-analysis. Clinical Nutrition, epub available online 21 January 2016
Podium Presentations

2015

  • Propofol – Emerging Clinical Evidence: Pharmacoeconomics of Propofol Sedation in the ICU ESA 2015 the European Anaesthesiology Congress. Berlin, Germany, May 30 – June 2, 2015
  • Alla ricerca dell’efficienza nella plasmaferesi: un confronto tra struttureIV Conferenza Nazionale dei Servizi Trasfusionali SIMTI. Naples, Italy, 29th May, 2015 (Podium presentation slides)
  • Pharmacoeconomics: Principles, Methods and Applications. Seminari di statistica, probabilità e ottimizzazione 2015, Politecnico di Torino, Turin, Italy, 14th April, 2015
Posters

2015

  • Pradelli L, Bellone M, Zaniolo O. Development of MS Budget Manager: a Practical Tool to Assist Alternative Stakeholders at Multiple Decision Levels in the Forecast and Financial Management for Multiple Sclerosis (MS). ISPOR 18th Annual European Congress, Milan, Italy, 7-11 November, 2015
  • Pradelli L, Bellone M, Era S, Campagnoli E. Cost-Effectiveness Analysis of Neo-Adjuvant Pertuzumab Therapy in Women With Locally Advanced, Inflammatory, or Early Her2-Positive Breast Cancer in Italy. ISPOR 18th Annual European Congress, Milan, Italy, 7-11 November, 2015
  • Povero M, Pradelli L. Biologic Treatments for Moderate to Severe Naïve Psoriatic Patients: A Budget Impact Analysis in Italy. ISPOR 18th Annual European Congress, Milan, Italy, 7-11 November, 2015
  • Eandi M, Marasca S, Povero M, D’Andrea A, Tieghi A, Randi V, Picardi F, Gandini G, Aprili G, Piani M,Velati C. Alla ricerca dell’efficienza nella plasmaferesi: un confronto tra strutture. SIMTI IV Conferenza Nazionale dei Servizi Trasfusionali, Naples, Italy, 28-30 May, 2015
  • L Pradelli, A Feuersenger, A Aliano, JF Baron, M Westphal. Short Term Sedation of Mechanically Ventilated ICU Patients With Propofol, Benzodiazepines, or Dexmedetomidine: Systematic Review and Meta-Analysis on Awakening and Recovery Times. ISICEM 35th International Symposium, Brussels, Belgium, 17-20 March, 2015
Papers

2015

  • ReadPovero M, Pradelli L. Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysis Farmeconomia. Health economics and therapeutic pathways 2015;16(S1):3-16.
  • ReadPovero M, Pradelli L. Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US. Farmeconomia. Health economics and therapeutic pathways 2015;16(3):77-86.
  • ReadWu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL. Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition. Clinicoecon Outcomes Res. 2015 Jun 26;7:369-75.
  • ReadPradelli L, Povero M, Muscaritoli M, Eandi M. Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. Eur J Clin Nutr 2015 May;69(5):546-51
  • ReadEandi M, Gandini G, Povero M, Zaniolo O, Pradelli L, Aprili G. Plasma for fractionation in a public setting: cost analysis from the perspective of the third-party payer. Blood Transfus 2015 Jan;13(1):37-45
Papers

2014

  • ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Comparative pharmaco-economic assessment of apixaban versus standard of care for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 15-25
  • ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 5-14
  • ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Cost effectiveness analysis of apixaban versus other NOACs  for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways 2014; 15(4): 101-112
  • ReadMancini N, Sambri V, Corti C, Ghidoli N, Tolomelli G, Paolucci M, Clerici D, Carletti S, Greco R, Tassara M, Pizzorno B, Zaniolo O, Povero M, Pradelli L, Burioni R, Stanzani M, Landini MP, Ciceri F, Clementi M. Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study. Expert Rev Mol Diagn 2014; 14(5): 623-32
  • ReadPradelli L, Eandi M, Povero M, Mayer K, Muscaritoli M, Heller AR, Fries-Schaffner E. Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. Clin Nutr 2014; 33(5): 785-92
  • ReadPovero M, Pradelli L, Turco P, Dal Negro RW. Real-life cost and cost-effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48-month survey. Farmeconomia. Health economics and therapeutic pathways 2014; 15(2): 39-44
Podium Presentations

2014

  • Goal Directed Perfusion (GDP): un’analisi dei costi differenziali in Italia. 7° Congresso Nazionale sihta, Rome, Italy, 25-27 September, 2014
  • What Are the Indicators of Cost-Effectiveness and Cost-Utility? ESPEN 36th Congress on Clinical Nutrition & Metabolism, Geneve, Switzerland, 6-9 September, 2014
  • Il giallo dell’autosufficienza. 10° Convention dei Centri Regionali del Sangue (CRS), Senigallia (AN), Italy, 12-14 June 2014
  • Pharmacoeconomics of Omega-3 Containing PN in ICU Patients. 42th Congress Hungarian Anesthesiology and Intensive Care Society (HAICS), Siòfok, Hungary, 22-24 May, 2014
  • Farmacoeconomía: Glutamina y Omega 3. XVIII Congreso Anual Avances en Metabolismo y Soporte Nutricional ACNC, Cartagena, Colombia, 1-3 May, 2014
Posters

2014

  • Zaniolo O, Povero M, Pradelli L, Pizzorno B, Mancini N. An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time PCR-Based Assay in Patients With Suspected Sepsis. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Hashim MS, Povero M, Aliano A, Pradelli L. Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; the French Context ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Povero M, Pradelli L. Goal Directed Perfusion (GDP): a Differential Cost Analysis in UK and US. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Budget Impact Analysis of Apixaban Versus other Noacs for the Prevention of Stroke in Italian non-Valvular Atrial Fibrillation Patients. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Cost Effectiveness Analysis of Apixaban Versus Other Noacs for the Prevention of Stroke in Italian non-Valvular Atrial Fibrillation Patients. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Pharmacoeconomic Assessment of Apixaban Versus Standard of Care for the Prevention of Stroke in Italian non-Valvular Atrial Fibrillation Patients. ISPOR 17th Annual European Congress, Amsterdam, The Netherlands, 8-12 November, 2014
  • Eandi M, Pradelli L, Della Pepa C, Povero M. Discrete Event Simulation of Haemophilia A Real-Life Management Strategies With FVIII: Integrating PK/PD, Epidemiology, Clinical Evidence, and Cost-Effectiveness Analysis. 17th World Congress of Pharmacology, Cape Town, South Africa, 13-18 July, 2014
Posters

2013

  • Povero M, Pradelli L, Bonadiman L, Dal Negro RW. Cost and Cost-effectiveness Analyses for Moderate and Severe COPD Patients Treated Uniquely With Tiotropium 18 mcg OD for Twenty-Four Months. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Povero M, Pitrelli A, Pradelli L. How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated With 5alpha-Reductase Inhibitors. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Giardina S, Ranucci M.
  • Lifetime Outcomes and Costs of Concomitant Aortic Valve Replacement in France and UK: the Performance of a Sutureless and Collapsed Valve. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Giardina S, Ranucci M. Lifetime Cost-Effectiveness of Isolated and Concomitant Aortic Valve Replacements in Germany. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Giardina S, Ranucci M. Lifetime Cost-Effectiveness of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a new Sutureless and Collapsed Valve in France and UK. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Povero M, Pradelli L. Potential Financial Impact of Sugammadex in Anaesthetic Departments: a Budget Impact Analysis on Potentially Short Procedures Requiring Neuromuscolar Blockade. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Zaniolo O, Povero M, Gandini G, Aprili G, Eandi M. Full Cost of Plasma From Voluntary non Remunerated Donors in Italy. ISPOR 16th Annual European Congress, Dublin, Ireland, November, 2013
  • Pradelli L, Zaniolo O, Muscaritoli M, Eandi M. Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients. ESPEN 35th congress, Leipzig, Germany, 31 August – 3 September, 2013 (Abstract’s Content View)
  • Pradelli L, Povero M. Potential of Omega-3 Fatty Acid in Parenteral Nutrition in Germany: a Budget Impact Analysis. ESPEN 35th Congress, Leipzig, Germany, 31 August – 3 September, 2013 (Abstract’s Content View)
Papers

2013

  • ReadPaggiaro P, Patel S, Nicolini G, Pradelli L, Zaniolo O, Papi A. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective. Respir Med 2013; 107(10): 1531-7
  • ReadBellone M, Sbarra P. A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations. Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 153-160
  • ReadZaniolo O, Povero M. ISPOR 2013: what’s new and what’s old? Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 151-152
  • ReadZaniolo O, Povero M, Bonfanti P, Borderi M, Medaglia M. First-line HIV treatment: evaluation of backbone choice and its budget impact. Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 75-87
  • ReadEandi M, Pradelli L, Povero M. Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 51-74
Podium Presentations

2013

  • Farmacoeconomia dei nutraceutici. XVI Congresso Nazionale SINPE, Ancona, Italy, 28-30 November, 2013
  • Sostituzione concomitante della valvola aortica con valvola sutureless: un’analisi di costo efficacia. 6° Congresso Nazionale sihta, Bari, Italy, 7-9 November, 2013